2352 Sunitinib as second-line treatment in patients with advanced intrahepatic cholangiocarcinoma: Final results of the SUN-CK phase II trial from GERCOR IRC

Authors :: Benoist Chibaudel
J.F. Seitz
Laetitia Fartoux
Mohamed Bouattour
Alexandre Amin
Gérard Lledo
A. de Gramont
Alexandra Hadengue
S. Faivre
S. Benner
Cindy Neuzillet
David Malka
N. Roldan
Chantal Dreyer
Eric Raymond
Annemilaï Tijeras-Raballand
Philippe Bourget
M. Granier
Maxime Ronot
Source :: European Journal of Cancer. 51:S452
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Second line treatment
business.industry
Sunitinib
Internal medicine
medicine
In patient
business
Intrahepatic Cholangiocarcinoma
medicine.drug

Full Text Access

Tools